Castle Hook Partners LP Adverum Biotechnologies, Inc. Transaction History

Castle Hook Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $3.11 Million - $6.41 Million	-1,082,549 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $1.17 Million - $1.98 Million	260,869 Added 31.75%	1,082,549 $6.55 Million
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $1.29 Million - $1.68 Million	243,902 Added 42.21%	821,680 $4.36 Million
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $2.11 Million - $4.59 Million	577,778 New	577,778 $3.35 Million

3.6M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $708M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Castle Hook Partners LP, based on Form 13F filings with the SEC.

Stay updated on Castle Hook Partners LP with notifications on news.